Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "MIM"

50 News Found

Aster DM Healthcare launches Pediatric & Geriatric Emergency Departments at Aster MIMS, Calicut
Healthcare | August 07, 2024

Aster DM Healthcare launches Pediatric & Geriatric Emergency Departments at Aster MIMS, Calicut

Both departments will be equipped with specialized professionals and state-of-the-art facilities ensuring the highest standards of care


Atik Cameras launches ChemiMOS for long exposure imaging
Medical Device | June 22, 2022

Atik Cameras launches ChemiMOS for long exposure imaging

Atik Cameras launches ChemiMOS; A 9MP CMOS camera for scientific applications


Aster MIMS Hospital completes 50 kidney swap transplants
Hospitals | April 06, 2022

Aster MIMS Hospital completes 50 kidney swap transplants

The kidney swap transplant procedure provides a solution to a critical shortage of compatible kidneys for patients suffering from kidney failures in India


TDB approves funding for MIM in MedTech
News | March 30, 2022

TDB approves funding for MIM in MedTech

Technology Development Board supports commercialisation of Metal Injection Molding of implants


Artificial retinal device mimics human optical illusions: WPI-MANA
Biotech | March 10, 2022

Artificial retinal device mimics human optical illusions: WPI-MANA

The team built a multiple ionic device system, each of which had a lithium cobalt oxide channel arranged on a common lithium phosphorus oxynitride electrolyte


Aster MIMS Kottakal has a new wing for women and children
Hospitals | September 14, 2021

Aster MIMS Kottakal has a new wing for women and children

It has been built at a cost of Rs 19.5 crores through internal accruals of the Malabar Institute of Medical Sciences (MIMS)


MilliporeSigma partners with Promega to advance 3-D cell drug discovery technologies
R&D | October 28, 2025

MilliporeSigma partners with Promega to advance 3-D cell drug discovery technologies

Partnership combines MilliporeSigma’s chemistry and organoid expertise with Promega’s assay technologies


Roche presents positive phase III data for vamikibart in uveitic macular edema
Clinical Trials | October 22, 2025

Roche presents positive phase III data for vamikibart in uveitic macular edema

Vamikibart is the first targeted, non-steroid treatment designed to address the underlying inflammation driving UME


Novo Nordisk's oral semaglutide gets EU approval for heart related treatment of type 2 diabet
News | September 16, 2025

Novo Nordisk's oral semaglutide gets EU approval for heart related treatment of type 2 diabet

EU approval makes Novo Nordisk’s oral semaglutide the first and only oral GLP-1 RA to reduce cardiovascular death, heart attack and stroke


Novo Nordisk’s amylin therapy cagrilintide shows significant weight loss in phase 3 trial
Clinical Trials | September 16, 2025

Novo Nordisk’s amylin therapy cagrilintide shows significant weight loss in phase 3 trial

Cagrilintide represents a novel approach to obesity management